Predictors of gallstone composition in 1025 symptomatic gallstones from Northern Germany

BMC Gastroenterology

Volumn 6, Issue , 2006, Pages

  Schafmayer, Clemens ^a   Hartleb, Jürgen ^b   Tepel, Jürgen ^a   Albers, Stefan ^a   Freitag, Sandra ^a   Völzke, Henry ^c   Buch, Stephan ^a   Seeger, Markus ^a   Timm, Birgit ^a   Kremer, Bernd ^a   Fölsch, Ulrich R ^a   Fändrich, Fred ^a   Krawczak, Michael ^a   Schreiber, Stefan ^a   Hampe, Jochen ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Arndt and Partner   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APATITE; BILIRUBIN; CALCIUM; CALCIUM CARBONATE; CHOLESTEROL; POLYSACCHARIDE; STEARIC ACID;

ADULT; AGED; ARTICLE; BIOCHEMICAL COMPOSITION; BODY MASS; CHOLECYSTECTOMY; CHOLESTEROL STONE; FEMALE; GALLSTONE; GERMANY; HUMAN; INFRARED SPECTROMETRY; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SEX DIFFERENCE;

AGE FACTORS; BILE PIGMENTS; BILIRUBIN; BODY MASS INDEX; CALCIUM; CHOLECYSTECTOMY; CHOLESTEROL; FEMALE; GALLSTONES; GERMANY; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; SEX DISTRIBUTION; SEX FACTORS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 33845328791     PISSN: 1471230X     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-6-36     Document Type: Article

References (36)

1. Lammert F, Sauerbruch T: Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol 2005, 2:423-433.
2. Volzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, John U, Lerch MM: Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 2005, 71:97-105.
3. Ransohoff DF, Grade WA: Treatment of gallstones. Ann Intern Med 1993, 119:606-619.
4. BQS Bundesgeschäftsstelle Qualitätssicherung: Cholezystektomie. In Qualität sichtbar machen BQS-Qualitätsreport 2004 Edited by: BQS Bundesgeschäftsstelle Qualitätssicherung. Düsseldorf; 2004:22-34.
5. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R: The burden of selected digestive diseases in the United States. Gastroenterology 2002, 122:1500-1511.
6. National Institutes of Health: Gallbladder and biliary disease. In Action plan for liver disease research A report of the Liver Diseases Subcommittee of the Digestive Diseases Interagency Coordinating Committee Edited by: U.S. Department of Health and Human Services. Bethesda, NIH; 2005:144-150.
7. Venneman NG, Renooij W, Rehfeld JF, van Berge-Henegouwen GP, Go PMNYH, Broeders IAMJ, van Erpecum KJ: Small Gallstones, Preserved Gallbladder Motility, and Fast Crystallization Are Associated with Pancreatitis. Hepatology 2005, 41:738-746.
8. Wang DQ, Afdhal NH: Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes. Curr Gastroenterol Rep 2004, 6:140-150.
9. Trauner M, Boyer JL: Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 2003, 83:633-671.
10. Kullak-Ublick GA, Stieger B, Meier PJ: Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 2004, 126:322-342.
11. Yu L, Gupta S, Xu F, Liverman AD, Moschetta A, Mangelsdorf DJ, Repa JJ, Hobbs HH, Cohen JC: Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J Biol Chem 2005, 280:8742-8747.
12. Moschetta A, Bookout AL, Mangelsdorf DJ: Prevertion of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 2004, 10:1352-1358.
13. Wang HH, Portinacase P, Wang DQ: Prevention of Cholesterol (Ch) Gallstones by the Potent Ch Absorption Inhibitor Ezetimibe in Gallstone-Susceptible Mice. Gastroenterology 2006, 130:A591.
14. Paigen B, Carey MC: Gallstones. In The genetic basis of common diseases Edited by: King RA. London, Oxford University Press; 2002:298-335.
15. Angwafo FF 3rd, Takongmo S, Griffith D: Determination of chemical composition of gall bladder stones: basis for treatment strategies in patients from Yaounde, Cameroon. World J Gastroenterol 2004, 10:303-305.
16. Ho KJ, Lin XZ, Yu SC, Chen JS, Wu CZ: Cholelithiasis in Taiwan. Gallstone characteristics, surgical incidence, bile lipid composition, and role of beta-glucuronidase. Dig Dis Sci 1995, 40:1963-1973.
17. Tsai WL, Lai KH, Lin CK, Chan HH, Lo CC, Hsu PI, Chen WC, Cheng JS, Lo GH: Composition of common bile duct stones in Chinese patients during and after endoscopic sphincterotomy. World J Gastroenterol 2005, 11:4246-4249.
18. Chihara G, Yamamoto S, Kameda H: Medical and biochemical application of infrared absorption spectra. I. Studies on gallstone by infrared spectra and X-ray chrystallography. Chem Pharm Bull (Tokyo) 1958, 6:50-54.
19. Trotman BW, Ostrow JD, Soloway RD: Pigment vs cholesterol cholelithiasis: comparison of stone and bile composition. Am J Dig Dis 1974, 19:585-590.
20. Krawczak M, Nikolaus S, von Eberstein H, El Mokhtari NE, Schreiber S: PopGen: Population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet 2006, 9:55-61.
21. Malet PF, Williamson CE, Trotman BW, Soloway RD: Composition of pigmented centers of cholesterol gallstones. Hepatology 1986, 6:477-481.
22. Milne JW: Ion exchange in alkali halide disks. Spectrochim Acta 1976, 32A:1347.
23. Ataman OY, Mark HB: Alkali Halide Pelleting Technique for Solid Sampling in Infrared Spectroscopy. Appl Spectroscopy Rev 1977, 13:1.
24. Keresztury G, Insze M, Seti F, Imre L: CO2 inclusion bands in infrared spectra of KBr pellets. Spectrochim Acta 1980, 36A:1007.
25. Malet PF, Weston NE, Trotman BW, Soloway RD: Cyclic deposition of calcium salts during growth of cholesterol gallstones. Scan Electron Microsc 1985:775-779.
26. Swidsinski A, Khilkin M, Pahlig H, Swidsinski S, Priem F: Time dependent changes in the concentration and type of bacterial sequences found in cholesterol gallstones. Hepatology 1998, 27:662-665.
27. Gustafsson U, Sahlin S, Einarsson C: High level of deoxycholic acid in human bile does not promote cholesterol gallstone formation. World J Gastroenterol 2003, 9:1576-1579.
28. Gustafsson U, Benthin L, Granstrom L, Groen AK, Sahlin S, Einarsson C: Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery. Hepatology 2005, 41:1322-1328.
29. Venneman NG, Portincasa P, Vanberge-Henegouwen GP, van Erpecum KJ: Cholesterol saturation rather than phospholipid/bile salt ratio or protein content affects crystallization sequences in human gallbladder bile. Eur J Clin Invest 2004, 34:656-663.
30. Yago MD, Gonzalez V, Serrano P, Calpena R, Martinez MA, Martinez-Victoria E, Manas M: Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease. Nutrition 2005, 21:339-347.
31. Taylor DR, Crowther RS, Cozart JC, Sharrock P, Wu J, Soloway RD: Calcium Carbonate in Cholesterol Gallstones: Polymorphism, Distribution and Hypothesis About Pathogenesis. Hepatology 1995, 22:488-496.
32. Trotman BW, Soloway RD: Pigment Gallstone Disease: Summary of the National Institutes of Health - International Workshop. Hepatology 1982, 2:879-884.
33. Stringer MD, Taylor DR, Soloway RD: Gallstone composition: are children different? J Pediatr 2003, 142:435-440.
34. Kleiner O, Ramesh J, Huleihel M, Cohen B, Kantarovich K, Levi C, Polyak B, Marks RS, Mordehai J, Cohen Z, Mordechal S: A comparative study of gallstones from children and adults using FTIR spectroscopy and fluorescence microscopy. BMC Gastroenterol 2002, 2:3.
35. Friedman GD, Kannel WB, Dawler TR: The epidemiology of gallstone disease: Observations in the Framingham study. J Chronic Dis 1966, 19:273-292.
36. van Erpecum KJ, van Berge Flenegouwen GP, Stoelwinder B, Stolk MF, Eggink WF, Govaert WH: Cholesterol and pigment gallstone disease: comparison of the reliability of three bile tests for differentiation between the two stone types. Scand J Gastroenterol 1988, 23:948-954.